Insider Selling: Trupanion (NASDAQ:TRUP) CFO Sells $137,005.86 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,177 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the transaction, the chief financial officer directly owned 2,081 shares in the company, valued at $46,156.58. This represents a 74.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Fawwad Qureshi also recently made the following trade(s):

• On Friday, February 27th, Fawwad Qureshi sold 2,837 shares of Trupanion stock. The shares were sold at an average price of $26.46, for a total value of $75,067.02.

Trupanion Trading Down 1.5%

Shares of NASDAQ:TRUP opened at $21.82 on Friday. The business’s 50-day moving average is $24.92 and its 200 day moving average is $30.34. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88. The firm has a market capitalization of $951.79 million, a P/E ratio of 36.98 and a beta of 1.49. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. During the same period in the prior year, the company posted ($0.03) EPS. The firm’s quarterly revenue was up 12.3% compared to the same quarter last year. On average, research analysts predict that Trupanion, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on TRUP shares. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Cantor Fitzgerald reduced their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Piper Sandler cut their price objective on Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Finally, Bank of America cut their price objective on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $42.25.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of TRUP. Federated Hermes Inc. acquired a new position in shares of Trupanion in the third quarter valued at about $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Trupanion in the third quarter valued at about $39,000. Parallel Advisors LLC increased its holdings in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new position in shares of Trupanion in the fourth quarter valued at about $64,000. Finally, Kelleher Financial Advisors acquired a new position in shares of Trupanion in the third quarter valued at about $74,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.